OrthoAccel Technologies, Inc. Announces Appointment of New Chief Financial Officer

HOUSTON, Dec. 5, 2012 /PRNewswire/ -- Pamela Westbrook has been named Chief Financial Officer, Vice President Finance & Administration for OrthoAccel Technologies (OrthoAccel®). In this position, she will oversee a broad range of corporate matters, including investor relations, financial reporting, treasury and taxation, information technology and organizational development for the company's global operations.

Ms. Westbrook has over 25 years of experience in finance and administration, primarily in the medical device industry. For the past five years, she has provided financial consulting services for a number of privately-owned start-up medical device companies, including OrthoAccel.  Prior to that, she served as CFO at Cyberonics, Inc. and the Physicians Resource Group. In addition, she was Vice President, Finance for SulzerMedica USA, Inc, and Vice President, Controller for Sulzer Carbomedics, Inc. She also held a Director-level position with Intermedics, Inc.

She graduated Cum Laude in Business Administration – Accounting from the University of Texas, Austin, and has been certified by the Texas State Board of Public Accountancy.

"We are absolutely delighted to welcome someone as qualified, experienced and skilled as Pam to OrthoAccel," says OrthoAccel CEO Mike Lowe. "As our business continues to grow both domestically and internationally, it's essential for our progress to be guided by sound financial principals and insight. We're entirely confident that Pam will provide those benefits. It's great to have her on board."

Ms. Westbrook joins OrthoAccel at the company's new offices in Bellaire, located in the Houston-Sugar Land metro area.

About OrthoAccel® Technologies, Inc.

Based in Houston, Texas, OrthoAccel Technologies, Inc. is a privately owned medical device company currently engaged in the development, manufacturing, and marketing of products to enhance dental care and orthodontic treatment.

OrthoAccel developed and sells AcceleDent™, the first FDA-cleared clinical approach to safely accelerate orthodontic tooth movement by applying precisely calibrated micropulses as a complement to existing orthodontic treatment. More information can be found at www.acceledent.com or requested via info@orthoaccel.com.

SOURCE OrthoAccel Technologies, Inc.

RELATED LINKS
http://www.acceledent.com